Cyclo Therapeutics, Inc.
CYTHDelisted Mar 26, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000922247
Cyclo Therapeutics, Inc. was delisted on Mar 26, 2025; its insiders filed their last Form 4 on Mar 3, 2025; 22 institutions reported holding it in 13F filings for Q4 2024, worth $1.33M in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding Cyclo Therapeutics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 19 | 22 | +3 |
| Shares | 2.28M | 2.26M | −15.7K (−0.7%) |
| Value | $1.80M | $1.33M | −$463.5K (−25.8%) |
New holders (4)
Institutions that held Cyclo Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 42,541 | $25.1K | 0.00% |
| FMR LLC | 30 | $18 | 0.00% |
| SBI Securities Co., Ltd. | 11 | $6 | 0.00% |
| BNP Paribas Arbitrage, SA | 1 | $1 | 0.00% |
Sold out (1)
Institutions that held Cyclo Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Princeton Global Asset Management LLC | 3,466 | $2.73K |